Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer

ErbB2 is an important member of the ErbB family, which activates growth and proliferation signaling pathways. ErbB2 is often overexpressed in various malignancies, especially in breast cancer, and is a common target for anti-cancer drugs. Breast cancer is currently one of the leading mortality cause...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Wolfson, Eya, Goldenberg, Maria, Solomon, Shira, Frishberg, Amit, Pinkas-Kramarski, Ronit
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2016
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5323158/
https://ncbi.nlm.nih.gov/pubmed/27542246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11323
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items